{"id":559953,"date":"2026-07-21T12:30:00","date_gmt":"2026-07-21T10:30:00","guid":{"rendered":"https:\/\/medizinonline.com\/?p=559953"},"modified":"2026-07-21T16:15:00","modified_gmt":"2026-07-21T14:15:00","slug":"potassium-binders-as-enablers-of-raasi-optimization","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/en\/potassium-binders-as-enablers-of-raasi-optimization\/","title":{"rendered":"Potassium binders as enablers of RAASi optimization"},"content":{"rendered":"\n

Renin-angiotensin-aldosterone system (RAAS) inhibitors\u2014including mineralocorticoid receptor antagonists (MRAs)\u2014are among the most effective tools in cardiorenal medicine. However, their benefits are often undermined in everyday clinical practice because fear of hyperkalemia leads to dose reduction or discontinuation. With the new potassium binders patiromer and sodium zirconium cyclosilicate (SZC), a well-studied strategy is now available for the first time that can overcome precisely this limitation: not to lower potassium for its own sake, but to enable and maintain life-prolonging RAASi therapy. The rapid rise of finerenone\u2014with hyperkalemia as a key safety signal\u2014lends new clinical urgency to this topic. <\/strong><\/p>\n\n

Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich
Jetzt beitreten<\/a><\/div>
Already a member? Log in here<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"

Renin-angiotensin-aldosterone system (RAAS) inhibitors\u2014including mineralocorticoid receptor antagonists (MRAs)\u2014are among the most effective tools in cardiorenal medicine. However, their benefits are often undermined in everyday clinical practice because fear of hyperkalemia……... <\/p>\n

Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich
Jetzt beitreten<\/a><\/div>
Already a member? Log in here<\/a><\/div><\/div><\/div>","protected":false},"author":7,"featured_media":559954,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Why the Finerenon Boom Is Giving Hyperkalemia Treatment New Relevance","footnotes":"","_members_access_role":[],"_members_access_error":""},"category":[11548,11359,11508,11297,11413,11503],"tags":[68007,17169,95167],"powerkit_post_featured":[],"class_list":["post-559953","post","type-post","status-publish","format-standard","has-post-thumbnail","category-rx-en","category-cardiology","category-education","category-general-internal-medicine","category-nephrology","category-studies","tag-finerenon-en","tag-hyperkalemia","tag-potassium-binder","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-08-05 20:29:05","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"en_US","wpml_translations":{"fr_FR":{"locale":"fr_FR","id":560757,"slug":"les-agents-de-fixation-du-potassium-catalyseurs-de-loptimisation-du-raasi","post_title":"Les agents de fixation du potassium, catalyseurs de l'optimisation du RAASi","href":"https:\/\/medizinonline.com\/fr\/les-agents-de-fixation-du-potassium-catalyseurs-de-loptimisation-du-raasi\/"},"it_IT":{"locale":"it_IT","id":560760,"slug":"i-leganti-del-potassio-come-fattori-abilitanti-per-lottimizzazione-del-raasi","post_title":"I leganti del potassio come fattori abilitanti per l\u2019ottimizzazione del RAASi","href":"https:\/\/medizinonline.com\/it\/i-leganti-del-potassio-come-fattori-abilitanti-per-lottimizzazione-del-raasi\/"},"pt_PT":{"locale":"pt_PT","id":560763,"slug":"os-ligantes-de-potassio-como-facilitadores-da-otimizacao-do-raasi","post_title":"Os ligantes de pot\u00e1ssio como facilitadores da otimiza\u00e7\u00e3o do RAASi","href":"https:\/\/medizinonline.com\/pt-pt\/os-ligantes-de-potassio-como-facilitadores-da-otimizacao-do-raasi\/"},"es_ES":{"locale":"es_ES","id":560766,"slug":"los-quelantes-de-potasio-como-factores-que-facilitan-la-optimizacion-del-raasi","post_title":"Los quelantes de potasio como factores que facilitan la optimizaci\u00f3n del RAASi","href":"https:\/\/medizinonline.com\/es\/los-quelantes-de-potasio-como-factores-que-facilitan-la-optimizacion-del-raasi\/"}},"_links":{"self":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts\/559953","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/comments?post=559953"}],"version-history":[{"count":1,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts\/559953\/revisions"}],"predecessor-version":[{"id":559955,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts\/559953\/revisions\/559955"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/media\/559954"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/media?parent=559953"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/category?post=559953"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/tags?post=559953"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/powerkit_post_featured?post=559953"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}